Canada markets closed

Aspen Pharmacare Holdings Limited (APNHY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
12.49+0.88 (+7.59%)
At close: 09:37AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 5.45B
Enterprise Value 6.77B
Trailing P/E 21.18
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.41
Price/Book (mrq)1.20
Enterprise Value/Revenue 0.16
Enterprise Value/EBITDA 0.84

Trading Information

Stock Price History

Beta (5Y Monthly) 0.75
52-Week Change 318.83%
S&P500 52-Week Change 322.38%
52 Week High 312.49
52 Week Low 38.35
50-Day Moving Average 311.17
200-Day Moving Average 310.17

Share Statistics

Avg Vol (3 month) 3193
Avg Vol (10 day) 3390
Shares Outstanding 5444.24M
Implied Shares Outstanding 6460.18M
Float 8278.49M
% Held by Insiders 10.00%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.18
Forward Annual Dividend Yield 41.44%
Trailing Annual Dividend Rate 33.42
Trailing Annual Dividend Yield 329.46%
5 Year Average Dividend Yield 41.23
Payout Ratio 431.11%
Dividend Date 3Oct 11, 2023
Ex-Dividend Date 4Sept 21, 2023
Last Split Factor 25:1
Last Split Date 3Jul 18, 2012

Financial Highlights

Currency in ZAR.

Fiscal Year

Fiscal Year Ends Jun 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 11.40%
Operating Margin (ttm)16.56%

Management Effectiveness

Return on Assets (ttm)4.10%
Return on Equity (ttm)6.05%

Income Statement

Revenue (ttm)42.7B
Revenue Per Share (ttm)96.12
Quarterly Revenue Growth (yoy)10.40%
Gross Profit (ttm)N/A
EBITDA 9.88B
Net Income Avi to Common (ttm)4.87B
Diluted EPS (ttm)0.59
Quarterly Earnings Growth (yoy)-13.50%

Balance Sheet

Total Cash (mrq)11.6B
Total Cash Per Share (mrq)26.1
Total Debt (mrq)36.12B
Total Debt/Equity (mrq)42.19%
Current Ratio (mrq)1.92
Book Value Per Share (mrq)192.66

Cash Flow Statement

Operating Cash Flow (ttm)6.27B
Levered Free Cash Flow (ttm)22.38M